Clinical Trial Update: Percutaneous Endocardial Septal Radiofrequency Ablation in Obstructive Hypertrophic Cardiomyopathy [NA]

View source ↗

Summary

Clinical trial update describing percutaneous endocardial septal radiofrequency ablation for obstructive hypertrophic cardiomyopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Hypertrophic Cardiomyopathy

Snippet

Sponsor: China National Center for Cardiovascular Diseases | Conditions: Obstructive Hypertrophic Cardiomyopathy | NA | Status: UNKNOWN